Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009–March 2010
Authors:
- Maja FolkenbergMFMaja Folkenberg
- Torbjörn CallréusTCTorbjörn Callréus
- Henrik SvanströmHSHenrik Svanström
- Palle Valentiner-BranthPVPalle Valentiner-Branth
- Anders HviidAHAnders Hviid
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009–January 31, 2010Vaccine, 2010
- Surveillance of adverse events following immunization against pandemic influenza in Slovenia in season 2009/10Vaccine, 2010
- The swine flu backlashThe Lancet, 2010
- Defining the safety profile of pandemic influenza vaccinesThe Lancet, 2010
- Possible hidden hazards of mass vaccination against new influenza A/H1N1: have the cardiovascular risks been adequately weighed?Medical Microbiology and Immunology, 2009
- Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant VaccineJAMA, 2009
- “Prepandemic” Immunization for Novel Influenza Viruses, “Swine Flu” Vaccine, Guillain‐Barré Syndrome, and the Detection of Rare Severe Adverse EventsThe Journal of Infectious Diseases, 2009
- The Signature Features of Influenza Pandemics — Implications for PolicyNew England Journal of Medicine, 2009
- Prepandemic H5N1 influenza vaccine adjuvanted with AS03: a review of the pre-clinical and clinical dataExpert Opinion on Biological Therapy, 2009
- Adverse Event Detection in Drug Development: Recommendations and Obligations Beyond Phase 3American Journal of Public Health, 2008